Home >> About

News & Events

NTSAD congratulates Marlene Jacobson, PhD, awardee of the 2015 Million Dollar Bike Ride grant made on behalf of Team NTSAD for her proposal entitled "Patient-Derived Phenotypic Assay to Discover Treatments for Tay-Sachs Disease."

Philadelphia, PA September 9th, 2015: Dr. Salim Merali (Moulder Center for Drug Discovery Research), Dr. Gunther Boden (Temple University Medical School) and their colleagues demonstrated that excessive caloric intake causes rapid onset of oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men.  Their findings were published in the internationally recognized journal Science Translational Medicine.

http://nypost.com/2015/09/14/the-american-diet-will-make-you-sick-in-jus...

https://www.yahoo.com/health/this-is-what-happened-when-1254722010800182...

http://www.cbsnews.com/news/these-men-ate-6000-calories-a-day-for-science/

Philadelphia, PA April 27, 2015 - Basic Principles of Drug Discovery and Development, a new textbook written by Dr. Benjamin E Blass and published by Academic Press, presents the multifaceted process of identifying a new drug in the modern era, providing comprehensive explanations of enabling technologies such as high throughput screening, structure based drug design, molecular modeling, pharmaceutical profiling, and translational medicine, all areas that have become critical steps in the successful development of marketable therapeutics.

March 25, 2015 - Dr. Carlos Barrero, a member of the Moulder Cetner for Drug Discovery Research, has been awarded a $300K grant from the Flight Attendant Medical Research Institute (FAMRI).  Over the course of this three year program, Dr. Barrero will be studying targeting Histone 3.3 receptors as a novel approach to the prevention of chronic obstructive pulmonary disease (COPD) progression.

Philadelphia, PA January 14, 2015 - Lonnie and Sharon Moulder, alumni of the Temple University School of Pharmacy, have pledged $5 million to endow the Moulder Center for Drug Discovery Research.  The Moulders donated $500,000 to help establish the academic drug discover center in 2007.

Philadelphia, PA December 14, 2014 - Laura H. Carnell Professor of Medicinal Chemistry, Associate Dean for Research and Director of the Moulder Center for Drug Discovery Research in Temple’s School of Pharmacy Magid Abou-Gharbia has won the prestigious Grand Hamdan International Award in Drug Discovery. Dr. Abou-Gharbia won the award in recognition for his outstanding contributions and pioneering work in medicinal chemistry and the discovery of several drugs, including the anti-cancer drug Torisel®, as well as the antidepressants Effexor® and Pristiq®.

December 11, 2014 - The Moulder Center for Drug Discovery Research will participate in the newly awarded NIH R01 grant entitled "“D3 Receptor Compounds for the Treatment of Psychostimulant Abuse” (2R01DA023957-06A1).  This 5 year program will be pursued in collaboration with Dr. Robert Luedtke (University of North Texas Health Science Center), Dr. Robert Mach (University of Pennsylvania), and Dr. Janet Neiesewander (Arizona State University).  Dr. Benjamin E Blass will serve as the principle investigator at the Moulder Center.

Each year the Philadelphia Business Journal announces Innovation Awards in several categories of endeavor. At an Award Reception on Thursday, October 24, 2014, Dr. Magid Abou-Gharbia received the Educator/Researcher Innovation Award of the Year 2014, and was recognized as the first among several candidates.

Philadelphia, PA Spetember 14, 2014 - The Moulder Center for Drug Discovery Research will participate in the newly awarded NIH R01 grant entitled "Targeting DNA Repair to Eradicate Tyrosine Kinase Inhibitor-Refractory/Resistant Chronic Myelogenous Lekemia" (5R01CA186238-02).  This five year, $2.5 MM program will be pursued as a collaborative effort with Dr. Tomasz Skorski (Temple School of Medicine) and Dr. Wayne E Childers (Temple School of Pharmacy, Moulder Center).

Magid Abou-Gharbia, Laura H. Carnell Professor of Medicinal Chemistry, was one of five former Wyeth (now Pfizer) scientists to be honored with the American Chemical Society’s 2014 Heroes of Chemistry award. He and his colleagues were recognized for their discovery of the antidepressant Effexor, regarded as a breakthrough therapy for depression, which has benefited over 25 million patients worldwide. Abou-Gharbia, who is also associate dean for research and director of the Moulder Center for Drug Discovery Research in the School of Pharmacy, was formerly senior vice president and head of chemical and screening sciences at Wyeth.

Pages

Temple University

Moulder Center for Drug Discovery Research

Temple University School of Pharmacy
3307 N Broad Street
Philadelphia, PA 19140